1 | 1 | | 85S10158 JG-D |
---|
2 | 2 | | By: Walle H.B. No. 109 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to the use of certain controlled substances by women who |
---|
8 | 8 | | are pregnant or may become pregnant and the designation of neonatal |
---|
9 | 9 | | abstinence syndrome from substance use as a reportable condition. |
---|
10 | 10 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
11 | 11 | | SECTION 1. Chapter 32, Health and Safety Code, is amended by |
---|
12 | 12 | | adding Subchapter E to read as follows: |
---|
13 | 13 | | SUBCHAPTER E. SUBSTANCE USE SCREENING DURING PREGNANCY |
---|
14 | 14 | | Sec. 32.081. SUBSTANCE USE SCREENING OF PREGNANT WOMAN. |
---|
15 | 15 | | The commission shall make available to physicians and other persons |
---|
16 | 16 | | capable of conducting a substance use screening of pregnant women |
---|
17 | 17 | | information that includes: |
---|
18 | 18 | | (1) guidance regarding the process for verbally |
---|
19 | 19 | | screening a pregnant woman for substance use using a validated |
---|
20 | 20 | | screening tool; and |
---|
21 | 21 | | (2) a list of substance use treatment resources in |
---|
22 | 22 | | each geographic region of this state. |
---|
23 | 23 | | SECTION 2. Section 81.041, Health and Safety Code, is |
---|
24 | 24 | | amended by adding Subsection (e-1) to read as follows: |
---|
25 | 25 | | (e-1) Neonatal abstinence syndrome is a reportable health |
---|
26 | 26 | | condition under this chapter for which the executive commissioner |
---|
27 | 27 | | shall require reports for public health surveillance purposes. A |
---|
28 | 28 | | person required to report a reportable disease under Section 81.042 |
---|
29 | 29 | | shall report a case of neonatal abstinence syndrome to the |
---|
30 | 30 | | department. |
---|
31 | 31 | | SECTION 3. Section 81.044, Health and Safety Code, is |
---|
32 | 32 | | amended by adding Subsection (e) to read as follows: |
---|
33 | 33 | | (e) The executive commissioner shall require a report of a |
---|
34 | 34 | | case of neonatal abstinence syndrome to omit personally identifying |
---|
35 | 35 | | information about the mother or newborn and to contain: |
---|
36 | 36 | | (1) the newborn's ethnicity, national origin, and |
---|
37 | 37 | | municipality and county of residence; |
---|
38 | 38 | | (2) the name of the newborn's attending physician; |
---|
39 | 39 | | (3) the maternal history of substance use; |
---|
40 | 40 | | (4) the drug or other substance that likely caused the |
---|
41 | 41 | | syndrome; and |
---|
42 | 42 | | (5) other information the executive commissioner |
---|
43 | 43 | | determines necessary. |
---|
44 | 44 | | SECTION 4. Chapter 161, Health and Safety Code, is amended |
---|
45 | 45 | | by adding Subchapter S-1 to read as follows: |
---|
46 | 46 | | SUBCHAPTER S-1. OPIOID DRUG USE AMONG PREGNANT WOMEN |
---|
47 | 47 | | Sec. 161.481. REVIEW OF PRESCRIPTION HISTORY. A physician |
---|
48 | 48 | | or other person authorized to attend a pregnant woman during |
---|
49 | 49 | | gestation and authorized to access prescription information under |
---|
50 | 50 | | Section 481.076(a)(5) may, during a pregnant patient's first visit |
---|
51 | 51 | | with the physician or person: |
---|
52 | 52 | | (1) review the patient's prescription history by |
---|
53 | 53 | | accessing the prescription information submitted to the Texas State |
---|
54 | 54 | | Board of Pharmacy as authorized by Section 481.076(a)(5) to assess: |
---|
55 | 55 | | (A) the pregnant patient's exposure to |
---|
56 | 56 | | prescription opioid drugs; and |
---|
57 | 57 | | (B) the possibility of the patient delivering a |
---|
58 | 58 | | newborn with neonatal abstinence syndrome; and |
---|
59 | 59 | | (2) place a record of the assessment in the patient's |
---|
60 | 60 | | medical record. |
---|
61 | 61 | | Sec. 161.482. EDUCATIONAL MATERIALS. (a) The department |
---|
62 | 62 | | shall develop educational materials on the consequences of opioid |
---|
63 | 63 | | drug use during pregnancy. |
---|
64 | 64 | | (b) The department shall make the educational materials |
---|
65 | 65 | | available on the department's Internet website. |
---|
66 | 66 | | SECTION 5. As soon as practicable after the effective date |
---|
67 | 67 | | of this Act, the executive commissioner of the Health and Human |
---|
68 | 68 | | Services Commission shall adopt rules necessary to implement the |
---|
69 | 69 | | changes in law made by this Act. |
---|
70 | 70 | | SECTION 6. (a) Not later than June 1, 2018, the Health and |
---|
71 | 71 | | Human Services Commission shall make the information regarding |
---|
72 | 72 | | verbally screening a pregnant woman for substance use and regarding |
---|
73 | 73 | | substance use treatment resources available to physicians and other |
---|
74 | 74 | | persons authorized by law to attend a pregnant woman, as required by |
---|
75 | 75 | | Section 32.081, Health and Safety Code, as added by this Act. |
---|
76 | 76 | | (b) Sections 81.041(e-1) and 81.044(e), Health and Safety |
---|
77 | 77 | | Code, as added by this Act, apply only to a case of neonatal |
---|
78 | 78 | | abstinence syndrome diagnosed in a child born on or after December |
---|
79 | 79 | | 1, 2018. |
---|
80 | 80 | | (c) The Department of State Health Services shall develop |
---|
81 | 81 | | and make available the educational materials under Section 161.482, |
---|
82 | 82 | | Health and Safety Code, as added by this Act, not later than March |
---|
83 | 83 | | 1, 2018. |
---|
84 | 84 | | SECTION 7. This Act takes effect on the 91st day after the |
---|
85 | 85 | | last day of the legislative session. |
---|